Skip to main content
Figure 2 | Alzheimer's Research & Therapy

Figure 2

From: Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies

Figure 2

CIBIC, changes in global performance. The changes in global performance (CIBIC) from the start of ChEI treatment over three years in mild AD. CIBIC score 1 to 3 was considered as improvement, 4 as unchanged and 5 to 7 as deterioration. Among the remaining patients in the study, 61% exhibited global improvement or no changes after one year, 43% after two years and 33% after three years of ChEI therapy. AD, Alzheimer’s disease; ChEI, cholinesterase inhibitor; CIBIC, Clinician’s Interview-Based Impression of Change.

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193